Cite

HARVARD Citation

    Rosenstock, J. et al. (n.d.). Long‐term 4‐year safety of saxagliptin in drug‐naive and metformin‐treated patients with Type 2 diabetes. Diabetic medicine. 30 (12), pp. 1472-1476. [Online]. 
  
Back to record